EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolite 4-hydroxybenzoic acid, modulated by cigarette smoke exposure, functions as a protective factor in dextran sodium sulfate-induced colitis

Masahiro Kitabatake, Tatsuki Nishioka, Atsushi Hara, Kaito Yasuike, Yumiko Nakanishi, Eiji Miyauchi, Noriko Ouji-Sageshima, Hiroshi Ohno, Toshihiro Ito

Journal of Gastroenterology · 2026

DOI: 10.1007/s00535-026-02484-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Masahiro Kitabatake und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. Hauptthemen laut MEDLINE: Colitis, Parabens, Cigarette Smoking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Smoking Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) is characterized by chronic gastrointestinal inflammation and comprises ulcerative colitis (UC) and Crohn’s disease (CD). Several cohort studies have shown that cigarette smoking (CS) is a risk factor for CD, but it has protective potential for UC. Although CS has been shown to cause different effects on UC and CD, the underlying mechanisms have not been fully determined.

Methods

Colitis was induced in CS-exposed mice using two different chemical-induced models: dextran sodium sulfate (DSS) and 2,4,6-trinitrobenzene sulfonic acid (TNBS). We examined pathology of the colon, effector lymphocytes, composition of the microbiota, and intestinal metabolites. We also examined the effect of an intestinal metabolite, 4-hydroxybenzoic acid (4-HBA), on DSS- and TNBS-induced colitis.

Results

CS exposure attenuated the pathogenesis of DSS-induced colitis by an increase in regulatory T cells (Tregs) accompanied by an increase in short-chain fatty acid production. By contrast, CS exacerbated TNBS-induced colitis by an increase in effector T cells and the abundance of Enterobacteriaceae , which were correlated with the pathogenesis of IBD. The administration of 4-HBA, which was remarkably increased by CS exposure in the DSS-induced colitis model, suppressed the colonic inflammation accompanying the induction of Tregs and suppression of effector T cells, but exerted no apparent protective effect against TNBS-induced colitis model.

Conclusion

CS may regulate colonic inflammation by altering the composition of the microbiota, intestinal metabolites, and immune responses. Additionally, mechanistic findings identified 4-HBA as a potential therapeutic target and provided insights into the development of new therapeutic approaches for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisParabensCigarette SmokingAnimalsDextran SulfateDisease Models, AnimalTrinitrobenzenesulfonic AcidMiceT-Lymphocytes, RegulatoryMice, Inbred C57BLMaleColonFatty Acids, VolatileGastrointestinal Microbiome

Stichwörter der Autor:innen

4-Hydroxybenzoic acidInflammatory bowel diseasesMicrobiotaMurine colitis modelsSmoking

Substanzen

Dextran SulfateTrinitrobenzenesulfonic AcidParabens4-hydroxybenzoic acidFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Immunology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
  • Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
  • RIKEN GENESIS CO., LTD, 1-2-2 Osaki, Shinagawa-ku, Tokyo, 141-0032, Japan.
  • Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8512, Japan.
  • Department of Immunology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. toshi-ito@naramed-u.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Smoking Research Foundation

Zitieren

APA

Kitabatake, M., Nishioka, T., Hara, A., Yasuike, K., Nakanishi, Y., Miyauchi, E., Ouji-Sageshima, N., Ohno, H., & Ito, T. (2026). Metabolite 4-hydroxybenzoic acid, modulated by cigarette smoke exposure, functions as a protective factor in dextran sodium sulfate-induced colitis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02484-4

Vancouver

Kitabatake M, Nishioka T, Hara A, Yasuike K, Nakanishi Y, Miyauchi E, et al. Metabolite 4-hydroxybenzoic acid, modulated by cigarette smoke exposure, functions as a protective factor in dextran sodium sulfate-induced colitis. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02484-4

BibTeX
@article{Kitabatake2026,
  author = {Kitabatake, Masahiro and Nishioka, Tatsuki and Hara, Atsushi and Yasuike, Kaito and Nakanishi, Yumiko and Miyauchi, Eiji and Ouji-Sageshima, Noriko and Ohno, Hiroshi and Ito, Toshihiro},
  title = {Metabolite 4-hydroxybenzoic acid, modulated by cigarette smoke exposure, functions as a protective factor in dextran sodium sulfate-induced colitis},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02484-4}
}
Kostenlos starten →